Search

everythinglearnresearchcommunity

for

Search:↓

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Erlotinib can cause persistent excessive hair growth.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Hormonal therapy is becoming a promising treatment for acne.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

A woman with severe angioedema improved significantly after treatment with rituximab.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Blocking mTORC1 reduces skin tumor growth in mice.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.